“Trade Alert — Biopharma Firm Poised for an Upsurge” from Ben Benoy

I hadn’t ever heard of Ben Benoy or the new Biotech Intel Trader that’s being published by Harry Dent’s company, but a few folks asked about it yesterday so I thought you might like a quick little answer to their teaser pitch. And actually, it’ll be even quicker than usual… more on that in a […]